[go: up one dir, main page]

HN1999000208A - Combinacion cerivastatina y fibratos - Google Patents

Combinacion cerivastatina y fibratos

Info

Publication number
HN1999000208A
HN1999000208A HN1999000208A HN1999000208A HN1999000208A HN 1999000208 A HN1999000208 A HN 1999000208A HN 1999000208 A HN1999000208 A HN 1999000208A HN 1999000208 A HN1999000208 A HN 1999000208A HN 1999000208 A HN1999000208 A HN 1999000208A
Authority
HN
Honduras
Prior art keywords
cerivastatin
combination
fibrate
fibrate combination
fibrates
Prior art date
Application number
HN1999000208A
Other languages
English (en)
Inventor
Joachim Ippen Ulrike Schopen
Reiner Ziegler Frits Schuckler
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HN1999000208A publication Critical patent/HN1999000208A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMBINACION DE CERIVASTATINA Y FIBRATOS.
HN1999000208A 1998-12-18 1999-11-30 Combinacion cerivastatina y fibratos HN1999000208A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19858789A DE19858789A1 (de) 1998-12-18 1998-12-18 Kombination von Cerivastatin und Fibraten

Publications (1)

Publication Number Publication Date
HN1999000208A true HN1999000208A (es) 2000-11-22

Family

ID=7891784

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000208A HN1999000208A (es) 1998-12-18 1999-11-30 Combinacion cerivastatina y fibratos

Country Status (19)

Country Link
US (1) US6511985B1 (es)
EP (1) EP1140082A1 (es)
KR (1) KR20010093845A (es)
CN (1) CN1330544A (es)
AR (1) AR021643A1 (es)
AU (1) AU3035600A (es)
BR (1) BR9916270A (es)
CA (1) CA2355295A1 (es)
CO (1) CO5160272A1 (es)
DE (1) DE19858789A1 (es)
GT (1) GT199900214A (es)
HN (1) HN1999000208A (es)
IL (1) IL143221A0 (es)
PE (1) PE20001325A1 (es)
PL (1) PL349389A1 (es)
SV (1) SV1999000250A (es)
TR (1) TR200101722T2 (es)
WO (1) WO2000037078A1 (es)
ZA (1) ZA200103918B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696084B2 (en) 2000-09-20 2004-02-24 Rtp Pharma Inc. Spray drying process and compositions of fenofibrate
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
ATE331512T1 (de) 2001-01-26 2006-07-15 Schering Corp Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie
MEP27808A (en) 2001-01-26 2010-10-10 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
ES2284646T3 (es) * 2001-02-22 2007-11-16 Jagotec Ag Combinaciones de estatina-fibrato con efectos secundarios en ayunas-alimentado reducidos.
EP1414496B1 (en) 2001-08-07 2010-10-20 Galephar M/F Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
WO2003013607A1 (en) * 2001-08-07 2003-02-20 Galephar M/F ORAL PHARMACEUTICAL COMPOSITION CONTAINING A COMBINATION OF FENOFIBRATE AND A HMG-CoA REDUCTASE INHIBITOR
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング　コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE10200138A1 (de) * 2002-01-04 2003-07-17 Karl Winkler Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7411045B2 (en) * 2002-11-19 2008-08-12 A&G Pharmaceutical, Inc. Autocrine growth factor receptor antibodies and methods
MXPA05009501A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
EP1606287B1 (en) 2003-03-07 2013-10-02 Merck Sharp & Dohme Corp. Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CA2526730A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives
WO2005046662A2 (en) * 2003-11-07 2005-05-26 Jj Pharma, Inc. Hdl-boosting combination therapy complexes
CA2597492A1 (en) * 2005-02-10 2006-08-17 Lifecycle Pharma A/S A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
US20070269503A1 (en) * 2006-05-16 2007-11-22 James Walter Burgess Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof
AR063469A1 (es) * 2006-07-14 2009-01-28 Ranbaxy Lab Ltd Formas polimorficas de ácido (3r,5r)-7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]-pirrol-1-il]-3, 5-dihidroxi-heptanoico, sal hemicalcio, metodos de preparacion de las mismas, una composicion farmaceutica que las comprende y su uso en el tratamiento de enfermedades
CA2657394A1 (en) 2006-08-04 2008-02-07 Aska Pharmaceutical Co., Ltd. Preparation containing fibrate agent and process for producing the same
TWI407955B (zh) 2007-03-29 2013-09-11 Kowa Co 高脂血症之預防及／或治療劑
WO2023146320A1 (ko) * 2022-01-28 2023-08-03 동광제약 주식회사 로수바스타틴 또는 이의 약학적으로 허용되는 염 및 페노피브레이트를 함유하는 캡슐 제제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (es) 1980-11-19 1986-01-10 Laruelle Claude
EP0276807A3 (en) 1987-01-27 1988-10-12 Warner-Lambert Company Lipid regulating compositions
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2039763A1 (en) * 1990-04-30 1991-10-31 Henry Y. Pan Combination of pravastatin and a fibric acid derivative, and method for treating dyslipidemia using such combination
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
FR2737121B1 (fr) 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
EP1017390B1 (en) * 1997-07-31 2007-04-18 Kos Life Sciences, Inc. Coated tablet comprising nicotinic acid or a compound metabolized to nicotinic acid in an extended release form, and a coating containing an hmg-coa reductase inhibitor in an immediate release form

Also Published As

Publication number Publication date
CO5160272A1 (es) 2002-05-30
IL143221A0 (en) 2002-04-21
ZA200103918B (en) 2002-05-15
AR021643A1 (es) 2002-07-31
SV1999000250A (es) 2000-10-16
PL349389A1 (en) 2002-07-15
CA2355295A1 (en) 2000-06-29
PE20001325A1 (es) 2000-12-30
EP1140082A1 (de) 2001-10-10
GT199900214A (es) 2001-06-08
AU3035600A (en) 2000-07-12
US6511985B1 (en) 2003-01-28
TR200101722T2 (tr) 2001-11-21
KR20010093845A (ko) 2001-10-29
WO2000037078A1 (de) 2000-06-29
BR9916270A (pt) 2001-09-04
DE19858789A1 (de) 2000-06-21
CN1330544A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
HN1999000208A (es) Combinacion cerivastatina y fibratos
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
HN1995009160A (es) Derivados de cicloalcano indol y azaindol
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
HN1999000066A (es) Formulaciones farmaceuticas
HN1998000124A (es) Terapia de combinacion
HN1999000089A (es) Formulaciones de ziprasidona
HN1998000139A (es) Pirimidin-4-ona y pirimidin-4-tiona novedosas como funguicidas
HN1997000097A (es) Piridinas condensadas con heterociclicos
HN1996000124A (es) 2-ox y 2- tio - 1, 2 dihidroquinolinil oxazolidinonas
HN1997000023A (es) Derivados de lactama
HN1998000002A (es) Compuestos de quinolina y de quinazolina utiles en terapia
HN1998003689A (es) Azetidinas
HN1998000030A (es) 2-amino-6-(4fenoxi-2-sustituido)-piridinas sustituidas
HN1998000106A (es) Composiciones parenterales de alatroflaxacino
HN1998000158A (es) Isoquinolinas
HN1998000185A (es) Combinaciones de estadina-eter carboxialquilico
HN1998000102A (es) Composiciones solubilizadas de sertralina
HN1998000165A (es) Polimorfos dofetilina
BR0114065A (pt) Triazolo-epotilonas
HN1997000119A (es) Formulaciones repelente
HN1999000038A (es) Nuevos compuestos fungicidas
HN1998000024U (es) Anillo promocional
HN1999000171A (es) Concentrado oral de sertralina.
HN1997000021A (es) Nuevas heteroariloxazolidinonas